| Literature DB >> 34147514 |
Jinguo Shi1, Yang Wang1, Jianwen Chen1, Yaoqiang Lao1, Ping Huang1, Liping Liao1, Caibao Jiang1, Xinhua Li1, Jin Wen1, Shujia Zhou1, Jingxia Zhang2.
Abstract
Here, we report the synthesis and neuroprotective capacity of 27 compounds with a bisphenol hydroxyl-substituted 1,2,4-triazole core or 1,2,4-oxadiazole core for stroke therapy. In vitro studies of the neuroprotective effects of compounds 1-27 on sodium nitroprusside (SNP)-induced apoptosis in PC12 cells indicate that compound 24 is the most effective compound conferring potent protection against oxidative injury. Compound 24 inhibits reactive oxygen species (ROS) accumulation and restores the mitochondrial membrane potential (MMP). Moreover, further analysis of the mechanism showed that compound 24 activates the antioxidant defence system by promoting the nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) and increasing the expression of haem oxygenase 1 (HO-1). An in vivo study was performed in a rat model of transient focal cerebral ischaemia generated by the intraluminal occlusion of the middle cerebral artery (MCAO). Compound 24 significantly reduced brain infarction and improved neurological function. Overall, compound 24 potentially represents a promising compound for the treatment of stroke.Entities:
Keywords: 1,2,4-oxadiazole; Fe(II) chelation; Ischemic stroke; Neuroprotection; Nrf2 signal pathway
Mesh:
Substances:
Year: 2021 PMID: 34147514 DOI: 10.1016/j.neuint.2021.105103
Source DB: PubMed Journal: Neurochem Int ISSN: 0197-0186 Impact factor: 3.921